Please use this identifier to cite or link to this item:
Title: Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.
Authors: Lee, S T;Ghanem, M;Herbertson, R A;Berlangieri, Salvatore U;Byrne, Amanda J;Tabone, K;Mitchell, Paul L R;Knight, Simon R;Feigen, Malcolm;Scott, Andrew M
Centre for PET, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 28-Mar-2009
Citation: Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging 2009; 11(6): 473-9
Abstract: To evaluate prognostic value of integrated 2-deoxy-2-[F-18]fluoro-D: -glucose-positron emission tomography/computed tomography (FDG-PET/CT) and correlate histopathological subtype with maximum standardized uptake value (SUV(max)) and survival in patients with malignant mesothelioma (MM).Retrospective review of FDG-PET/CT scans, with derivation of SUV(max) of FDG-avid lesions, was performed in patients with biopsy-proven MM. Clinical follow-up and Kaplan-Meier survival analysis was performed.Forty-six patients (37 M:9 F; mean age 61 years) with MM had a FDG-PET/CT scan in a 30-month period. Follow-up was available on 44/46 (96%) patients. Metastatic disease was detected in 9/46 (20%) patients on FDG-PET/CT, where 8/9 were previously undetected. Better survival was found in patients without metastases (p value < 0.05). Mean SUV(max) of primary pleural lesions in patients with metastatic disease was significantly higher than in patients without metastatic disease (p value < 0.05). Progression-free survival was significantly better in the epithelioid histology group compared to the biphasic group (p value 0.015).Detection of extrathoracic metastases on FDG-PET/CT and nonepithelioid histopathology are poor prognostic indicators in patients with MM.
Internal ID Number: 19330385
DOI: 10.1007/s11307-009-0203-6
Type: Journal Article
Subjects: Adult
Aged, 80 and over
Disease-Free Survival
Fluorodeoxyglucose F18.diagnostic use.metabolism
Follow-Up Studies
Kaplan-Meier Estimate
Mesothelioma.pathology.radiography.radionuclide imaging
Middle Aged
Pleural Neoplasms.pathology.radiography.radionuclide imaging
Positron-Emission Tomography.methods
Radiopharmaceuticals.diagnostic use.metabolism
Time Factors
Tomography, Emission-Computed.methods
Appears in Collections:Journal articles

Files in This Item:
File SizeFormat 
19330385.pdf55.68 kBAdobe PDFView/Open

Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.